4//SEC Filing
VAN OORT DOUGLAS M 4
Accession 0001077183-20-000118
CIK 0001077183other
Filed
May 26, 8:00 PM ET
Accepted
May 27, 5:24 PM ET
Size
11.3 KB
Accession
0001077183-20-000118
Insider Transaction Report
Form 4
VAN OORT DOUGLAS M
DirectorChairman and CEO
Transactions
- Tax Payment
Common Stock
2020-05-25−22,330→ 2,293,743 total
Holdings
- 500,000
Stock Option (Right to Buy)
Exercise: $8.03From: 2019-02-26Exp: 2023-02-26→ Common Stock (500,000 underlying) - 225,084
Stock Option (Right to Buy)
Exercise: $28.33From: 2021-03-02Exp: 2027-03-02→ Common Stock (225,084 underlying) - 10,000(indirect: By Children)
Common Stock
- 500,000
Stock Option (Right to Buy)
Exercise: $7.52From: 2018-04-28Exp: 2022-04-28→ Common Stock (500,000 underlying) - 231,567
Stock Option (Right to Buy)
Exercise: $19.60From: 2020-03-01Exp: 2024-03-01→ Common Stock (231,567 underlying)
Footnotes (5)
- [F1]Shares surrendered to NeoGenomics Inc. to satisfy the tax obligations in connection with the May 25, 2020 vesting of restricted stock.
- [F2]On April 28, 2017, Mr. VanOort was granted 500,000 stock options. These options vest ratably over the first three anniversary dates of the grant date.
- [F3]On February 26, 2018, Mr. VanOort was granted 500,000 stock options. These options vest ratably over the first three anniversary dates of the grant date.
- [F4]On March 1, 2019, Mr. VanOort was granted 231,567 stock options. These options vest ratably over the first four anniversary dates of the grant date.
- [F5]On March 2, 2020, Mr. VanOort was granted 225,084 stock options. These options vest ratably over the first four anniversary dates of the grant date.
Documents
Issuer
NEOGENOMICS INC
CIK 0001077183
Entity typeother
Related Parties
1- filerCIK 0001518733
Filing Metadata
- Form type
- 4
- Filed
- May 26, 8:00 PM ET
- Accepted
- May 27, 5:24 PM ET
- Size
- 11.3 KB